School of Public Health, Zhengzhou University, Henan, China.
School of Pharmacy, Zhengzhou University, Henan, China.
Environ Pollut. 2022 Jan 1;292(Pt A):118272. doi: 10.1016/j.envpol.2021.118272. Epub 2021 Oct 28.
Silicosis is a disease mainly caused by pulmonary interstitial fibrosis caused by long-term inhalation of dust with excessively high content of free SiO. Transdifferentiation of lung fibroblasts into myofibroblasts is an important cellular basis for silicosis, but the key transcription factors (TFs) involved in this process are still unclear. In order to explore the biological regulation of transcription factor PPARγ/LXRα in silica-induced pulmonary fibrosis, this study explored the molecular mechanism of PPARγ/LXRα involved in regulating transcription factors related to SiO-induced lung injury at the cellular level and in animal models. ChIP-qPCR detected that PPARγ directly regulated the transcriptional activity of the LXRα gene promoter, while the PPARγ agonist RSG increased the expression of LXRα. In addition, we demonstrated in the cell model that upregulation of LXRα can inhibit silica-mediated fibroblast transdifferentiation, accompanied by an increase in the expression of SREBF1, PLTP and ABCA1. The results of LXRα silencing experiment matched those of overexpression experiment. These studies explored the role of LXRα in plasticity and phenotypic transformation between lung fibroblasts and myofibroblasts. Therefore, inhibiting or reversing the transdifferentiation of lung fibroblasts to myofibroblasts by intervening PPARγ/LXRα may provide a new therapeutic target for the treatment of silicosis.
矽肺是一种主要由长期吸入游离二氧化硅含量过高的粉尘引起的肺间质纤维化疾病。肺成纤维细胞向肌成纤维细胞的转分化是矽肺的重要细胞学基础,但这一过程涉及的关键转录因子(TFs)仍不清楚。为了探讨转录因子 PPARγ/LXRα 在二氧化硅诱导的肺纤维化中的生物学调控作用,本研究在细胞水平和动物模型中探索了 PPARγ/LXRα 调节与 SiO 诱导肺损伤相关转录因子的分子机制。ChIP-qPCR 检测到 PPARγ 可直接调节 LXRα 基因启动子的转录活性,而 PPARγ 激动剂 RSG 增加了 LXRα 的表达。此外,我们在细胞模型中证明,上调 LXRα 可以抑制二氧化硅介导的成纤维细胞转分化,同时 SREBF1、PLTP 和 ABCA1 的表达增加。LXRα 沉默实验的结果与过表达实验的结果相匹配。这些研究探讨了 LXRα 在肺成纤维细胞和肌成纤维细胞之间可塑性和表型转化中的作用。因此,通过干预 PPARγ/LXRα 抑制或逆转肺成纤维细胞向肌成纤维细胞的转分化,可能为矽肺的治疗提供新的治疗靶点。